Orange Book product · Generic (ANDA)
PHENOXYBENZAMINE HYDROCHLORIDE
PHENOXYBENZAMINE HYDROCHLORIDE
At a glance
Jul 19, 2022
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 19, 2022
4 yr ago
Today
Pharmaceutical detail
Active ingredient
PHENOXYBENZAMINE HYDROCHLORIDE
Strength
10MG
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
ANDA 215042
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of PHENOXYBENZAMINE HYDROCHLORIDE
- —DIBENZYLINEBrand (NDA)
NDA 008708 · ADVANZ PHARMA
- 2023PHENOXYBENZAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 204551 · RISING
- 2023PHENOXYBENZAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 215600 · AUROBINDO PHARMA
- 2020PHENOXYBENZAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 212568 · AMNEAL
- 2017PHENOXYBENZAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 204522 · PH HEALTH
- 2012PHENOXYBENZAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 201050 · HIKMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
